+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
Antibiotics Market 2024-2028 - Product Thumbnail Image

Antibiotics Market 2024-2028

  • Report
  • May 2024
  • 170 Pages
  • Global
From
Penicillin Market 2024-2028 - Product Thumbnail Image

Penicillin Market 2024-2028

  • Report
  • March 2024
  • 165 Pages
  • Global
From
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
From
Drugs For Benign Prostatic hypertrophy Global Market Report 2024 - Product Thumbnail Image

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Loading Indicator